Literature DB >> 26393531

Vagus Nerve Stimulation for Epilepsy: An Evidence-Based Approach.

Arthur Cukiert1.   

Abstract

Medical treatment of seizures yields a satisfactory response in 75-80% of the patients; resective epilepsy surgery is a therapeutic option for those patients who are refractory to drug therapy, but there is still a considerable portion (20-30%) of patients who are ineligible for surgery or failed surgery. Vagus nerve stimulation (VNS) might be an option for these very refractory patients. We carried out an evidence-based search to identify the best evidence presently available related to the use of VNS. We used multiple searchable databases (primary: PubMed-MEDLINE, EMBASE, LILACS, and SciELO; secondary: Cochrane Library) and a standard structured approach know as the PICO scheme: P (patient), I (intervention), C (comparison), and O (outcome). Publications were selected based on study design, PICO components, language, and availability of full text. For study design, we included papers designed as 'randomized controlled trials'; these trials were evaluated according to the Jadad score; the type II error was not used while selecting studies to avoid further limitations. Twenty-eight papers were selected, all from PubMed-MEDLINE. The search results showed that patients older than 12 years with refractory partial seizures (with or without generalization) may benefit from VNS. Children might also benefit, but might need different stimulation parameters. We also noted that higher stimulation settings are associated with increased occurrence of hoarseness, throat pain, cough, and dyspnea. The available randomized controlled trials and cohorts made it clear that VNS is a useful palliative procedure in adult patients with partial epilepsy, and a 50-60% reduction in seizure frequency might be expected in at least 50% of the patients. VNS is a useful palliative procedure in patients with refractory epilepsy. As our practical experience and understanding of the mechanism of action of VNS increase, more homogeneous patient populations that might respond better to VNS are being recognized, such as children with secondary generalized epilepsy and some types of reflex epilepsy.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26393531     DOI: 10.1159/000434654

Source DB:  PubMed          Journal:  Prog Neurol Surg        ISSN: 0079-6492


  7 in total

Review 1.  Vagus nerve stimulation for focal seizures.

Authors:  Mariangela Panebianco; Alexandra Rigby; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2022-07-14

Review 2.  Vagus Nerve Stimulation at the Interface of Brain-Gut Interactions.

Authors:  Bruno Bonaz; Valérie Sinniger; Sonia Pellissier
Journal:  Cold Spring Harb Perspect Med       Date:  2019-08-01       Impact factor: 6.915

3.  Early Gabapentin Treatment during the Latency Period Increases Convulsive Threshold, Reduces Microglial Activation and Macrophage Infiltration in the Lithium-Pilocarpine Model of Epilepsy.

Authors:  Alicia Rossi; Veronica Murta; Jerónimo Auzmendi; Alberto Javier Ramos
Journal:  Pharmaceuticals (Basel)       Date:  2017-11-28

Review 4.  High-Resolution Multi-Scale Computational Model for Non-Invasive Cervical Vagus Nerve Stimulation.

Authors:  Antonios P Mourdoukoutas; Dennis Q Truong; Devin K Adair; Bruce J Simon; Marom Bikson
Journal:  Neuromodulation       Date:  2017-10-27

5.  Similarities between the responses to ANT-DBS and prior VNS in refractory epilepsy.

Authors:  Toni Kulju; Joonas Haapasalo; Kai Lehtimäki; Sirpa Rainesalo; Jukka Peltola
Journal:  Brain Behav       Date:  2018-05-08       Impact factor: 2.708

Review 6.  Health Technology Assessment Report on Vagus Nerve Stimulation in Drug-Resistant Epilepsy.

Authors:  Carlo Efisio Marras; Gabriella Colicchio; Luca De Palma; Alessandro De Benedictis; Giancarlo Di Gennaro; Marilou Cavaliere; Elisabetta Cesaroni; Alessandro Consales; Sofia Asioli; Massimo Caulo; Flavio Villani; Nelia Zamponi
Journal:  Int J Environ Res Public Health       Date:  2020-08-24       Impact factor: 3.390

7.  Altered amplitude of low-frequency fluctuations and regional homogeneity in drug-resistant epilepsy patients with vagal nerve stimulators under different current intensity.

Authors:  Jin Zhu; Cuiping Xu; Xi Zhang; Liang Qiao; Xueyuan Wang; Xiaohua Zhang; Xiaoming Yan; Duanyu Ni; Tao Yu; Guojun Zhang; Yongjie Li
Journal:  CNS Neurosci Ther       Date:  2020-09-23       Impact factor: 5.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.